Efficacy and Safety Study With MYL-1401H and Neulasta

Update Il y a 4 ans
Reference: NCT02467868

Woman and Man

Extract

This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and Safety Study of MYL-1401H and Neulasta (Pegfilgrastim) in Stage II/III Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy.


Inclusion criteria

  • Breast Neoplasms ,Chemotherapy-induced Febrile Neutropenia


Links